Popular keyword search:
Search
Your location:Home > News centre > Company News

NEWS

HOT NEWS

Aweituo will meet with you at the 2021 Shanghai Alumni Annual Conference of China Pharmaceutical Uni

Time:2021-07-06

Views:624

The annual China Pharmaceutical University Shanghai Alumni Conference will be held in Zhangjiang, Shanghai on July 3rd. This annual meeting will focus on the challenges faced by the pharmaceutical industry in the post-Yi situation era. How do pharmaceutical colleagues face the market dynamics? What expectations do you have for the future? The idea of the development of the industry and so on to carry out in-depth exchange and discussion!


Time: July 3, 2021, 13:00-16:00

Venue: Boya Hotel, 699 Bibo Road, Pudong New Area, Shanghai


As an alumnus of PHU, Aweituo is very honored to sponsor this event. As the president of CPU-SH R & D & Production Branch, Dr. Cao Liang, the general manager of Aituo, presided over the meeting with all alumni and partners to realize the collision of thinking and build a new future of medicine together!

Report 1:

Report on the topic

Biomedical early and mid - term investment sharing

speakers

PangXiuBing

The report summary

Share investment in the early and middle stages of innovative drugs, high DUAN devices and new diagnostics


Report 2:

Report on the topic

Innovative technology for patent medicine is the last mile -- delivery technology

speakers

Ling Yan (Head of Bozhi Research New Biology Platform)

The report summary

Introduction of small molecule, PROTAC, insoluble drug solubility technology, exosomes, viral vectors and other delivery technologies.


Report 3:

Report on the topic

Development of mRNA technology and development of microorganism mRNA vaccine

speakers

Expericnce article

The report summary

The rapid marketing of mRNA vaccines has led the biomedical industry into the era of the third generation of vaccines. Due to the superiority of its technical route, mRNA vaccines have great advantages in the prevention of infectious diseases compared with traditional vaccines.

Report four:

Report on the topic

Key points of concern for non-clinical safety evaluation of biotech drugs

speakers

Shuangqing Peng (Chief Scientific Officer, Medicium Biopharmaceuticals)

The report summary

Due to the difference between biotech drugs and small molecule drugs, traditional chemical drug evaluation methods may not be suitable for the evaluation of large molecule drugs. Based on the diversity of biotech drugs, analysis is made on a case-by-case basis. The selection of relevant animal species and models, the setting of immunogenicity and the evaluation dose will be the key issues that need to be paid attention to. At the same time, the comprehensive analysis strategy of weight of evidence can be introduced for the evaluation of reproductive and developmental toxicity and AI-induced toxicity.
在线咨询
Service
Landline
021-58876118
Hotline
13916637505